CAG
VRTX icon

Crestwood Advisors Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Crestwood Advisors Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
7,184
-572
-7% -$254K 0.05% 178
2026
Q1 		$3.46M Sell
7,756
-247
-3% -$115K 0.06% 174
2025
Q4 		$3.63M Sell
8,003
-1,148
-13% -$495K 0.06% 166
2025
Q3 		$3.58M Sell
9,151
-892
-9% -$373K 0.06% 160
2025
Q2 		$4.47M Sell
10,043
-232
-2% -$107K 0.08% 141
2025
Q1 		$4.98M Buy
10,275
+4,476
+77% +$2.09M 0.09% 127
2024
Q4 		$2.34M Buy
5,799
+121
+2% +$56.1K 0.04% 175
2024
Q3 		$2.64M Buy
5,678
+46
+0.8% +$22.1K 0.05% 164
2024
Q2 		$2.64M Buy
5,632
+99
+2% +$43K 0.05% 151
2024
Q1 		$2.31M Buy
5,533
+436
+9% +$184K 0.05% 159
2023
Q4 		$2.07M Buy
5,097
+90
+2% +$33.2K 0.05% 159
2023
Q3 		$1.74M Buy
+5,007
New +$1.75M 0.05% 163
2021
Q1 		– Sell
-1,230
Closed -$291K – 279
2020
Q4 		$291K Sell
1,230
-178
-13% -$40.8K 0.01% 216
2020
Q3 		$383K Buy
1,408
+3
+0.2% +$828 0.01% 182
2020
Q2 		$408K Sell
1,405
-7
-0.5% -$1.9K 0.02% 176
2020
Q1 		$336K Buy
1,412
+7
+0.5% +$1.61K 0.02% 173
2019
Q4 		$308K Sell
1,405
-50
-3% -$10.1K 0.01% 209
2019
Q3 		$247K Sell
1,455
-1
-0.1% -$177 0.01% 220
2019
Q2 		$267K Buy
+1,456
New +$255K 0.01% 203

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Crestwood Advisors Group's VRTX Position: Q2 2026 in Review

Crestwood Advisors Group reduced its Vertex Pharmaceuticals (VRTX) stake by 7.4% in Q2 2026, selling an estimated $254K and leaving 7,184 shares worth $3.57M. The position accounts for 0.05% of the portfolio, ranked #178.

Crestwood Advisors Group first reported a position in VRTX in Q2 2019 and has held it in 19 quarters since. The position peaked at $4.98M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Crestwood Advisors Group held 7,184 shares of Vertex Pharmaceuticals worth $3.57M as of Q2 2026.
  • Crestwood Advisors Group sold 572 Vertex Pharmaceuticals shares in Q2 2026, an estimated $254K.
  • Vertex Pharmaceuticals made up 0.05% of Crestwood Advisors Group's portfolio in Q2 2026, its #178 holding.
  • Crestwood Advisors Group first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 19 quarters since.
  • Crestwood Advisors Group's Vertex Pharmaceuticals position peaked at $4.98M in Q1 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.